OraSure Technologies Inc

Financials

Cash from operating activities 12.68 M109 K-19.73 M-10.22 M-10.07 M -39.92 M Cash from investing activities 7.33 M-5.49 M370 K-1.94 M-821 K -7.88 M Cash from financing activities -726 K-111 K-953 K-5.8 M-5.08 M -11.94 M Free cash flow 12.54 M-347 K-20.15 M-12.16 M-10.99 M -43.65 M

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

OSUR

Financials

OraSure Technologies Inc

Haberler

OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript

OraSure: EPS erfüllt Schätzungen - Umsatz schlechter als erwartet

OraSure earnings matched, revenue fell short of estimates

Earnings Call: OraSure Technologies verfehlt Umsatzprognose für Q4 2025

OraSure’s HIV self-test receives Health Canada license

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates

Altai Capital nominiert zwei Direktoren für Verwaltungsrat von OraSure Technologies/n

Altai Capital nominates two directors for OraSure Technologies board

Unzufriedenheit mit Aktienkurs: Altai Capital nominiert zwei Kandidaten für den Aufsichtsrat von OraSure

Altai Capital nominates two directors to OraSure board amid concerns

OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device

OraSure submits FDA applications for rapid STI test and collection device